Cube&Company Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cube&Company Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
iNtRON Biotechnology Inc
sales of 8.35 billion Korean Won [US$7.10 million]
of which 75%
was Gene Extraction/Amplification),
(4.37 billion Korean Won [US$3.71 million]
of which 67%
was Medical Segment), and
FutureChem Co Ltd
(8.17 billion Korean Won [US$6.94 million]
Cube&Company Co Ltd reported sales of 7.38 billion Korean Won (US$6.27 million)
December of 2019.
decrease of 34.4%
versus 2018, when the company's sales were 11.24 billion Korean Won .
Contributing to the drop in overall sales was the 93.6% decline
in Other, from 1.88 billion Korean Won to 119.66 million Korean Won .
There were also decreases in sales in
Synthesis (down 22.5% to 7.26 billion Korean Won )